Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 15Carcinoma, Non-Small-Cell Lung 11Lung Neoplasms 10Unspecified Adult Solid Tumor, Protocol Specific 6Breast Neoplasms, Male 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Melanoma 5Lymphoma, Non-Hodgkin 5Lymphoma, Mantle-Cell 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Head and Neck Neoplasms 5Prostatic Neoplasms 4Neoplasm Metastasis 4Leukemia, Lymphocytic, Chronic, B-Cell 4Congenital Abnormalities 4Central Nervous System Neoplasms 4Carcinoma, Ovarian Epithelial 4Brain Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Sarcoma 3Neoplasms 3Myeloproliferative Disorders 3Myelodysplastic Syndromes 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Leukemia 3Kidney Neoplasms 3Carcinoma, Renal Cell 3

Interventions

Carboplatin 69Paclitaxel 47Radiotherapy 44Pemetrexed 42Cisplatin 41Bevacizumab 36Gemcitabine 27Docetaxel 27Erlotinib Hydrochloride 23Gefitinib 18pembrolizumab 14Taxes 13Vinorelbine 10Cetuximab 10Radiation 8Nivolumab 8Magnetic Resonance Spectroscopy 8Radiosurgery 7Platinum 7Etoposide 7Surgical Procedures, Operative 6Radiotherapy, Conformal 6ceritinib 5capmatinib 5aflutinib 5Specimen Handling 5Neoadjuvant Therapy 5Mastectomy, Segmental 5Cyclophosphamide 5tislelizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Adenocarcinoma of Lung × Immunoenzyme Techniques × Clear all
NCT00560495 2022-10-03

Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Roswell Park Cancer Institute

Phase 1 Withdrawn
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡